ST. VINCENT HOSPITAL & HCC
- Type
- Teaching hospital
- Where
- INDIANAPOLIS, IN
- Medicare CCN
- 150084
- Received
- $429,224 in 53 records, 2020 ($38,380 general, $390,844 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 15 | $38,380 |
| 2020 | Research payment | 38 | $390,844 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 3 | $279,465 | 2020 |
| Regeneron Pharmaceuticals, Inc. | 2 | $24,920 | 2020 |
| Celgene Corporation | 1 | $22,125 | 2020 |
| Eli Lilly and Company | 1 | $21,030 | 2020 |
| Medical Device Business Services, Inc. | 1 | $20,000 | 2020 |
| Karyopharm Therapeutics Inc. | 4 | $13,350 | 2020 |
| Stryker Corporation | 3 | $8,417 | 2020 |
| AstraZeneca Pharmaceuticals LP | 2 | $8,406 | 2020 |
| Baxter Healthcare | 2 | $5,569 | 2020 |
| Abbott Laboratories | 5 | $5,194 | 2020 |
| AXOGEN | 1 | $3,850 | 2020 |
| Genentech, Inc. | 3 | $3,364 | 2020 |
| Pharmacyclics LLC, an AbbVie Company | 7 | $2,800 | 2020 |
| PFIZER INC. | 4 | $2,779 | 2020 |
| Surmodics, Inc. | 2 | $2,053 | 2020 |
| Linvatec Corporation | 2 | $1,278 | 2020 |
| Allergan, Inc. | 1 | $1,200 | 2020 |
| Zimmer Biomet Holdings, Inc. | 1 | $1,095 | 2020 |
| Genentech USA, Inc. | 1 | $775 | 2020 |
| UCB, Inc. | 1 | $775 | 2020 |
| Aesculap Implant Systems, LLC | 1 | $500 | 2020 |
| FUJIFILM SonoSite, Inc. | 1 | $196 | 2020 |
| Siemens Medical Solutions USA, Inc. | 1 | $43 | 2020 |
| Incyte Corporation | 3 | $37 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 38 | $390,844 |
| Grant | 3 | $21,278 |
| Gift | 3 | $7,722 |
| Space rental or facility fees (teaching hospital only) | 5 | $4,840 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $3,099 |
| Education | 2 | $1,396 |
| Charitable Contribution | 1 | $43 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Stryker Corporation | $6,127 | Gift | In-kind items and services | NSE - HIGH SPEED DRILLS Device, NEURO SPINE ENT | 2020 | |
| 2020-12-31 | Linvatec Corporation | $747 | Grant | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-12-31 | AstraZeneca Pharmaceuticals LP | $450 | Research payment | In-kind items and services | LYNPARZA Drug, Oncology | A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Pati | 2020 |
| 2020-12-31 | Abbott Laboratories | $150 | Research payment | In-kind items and services | TriClip Transcatheter Tricuspid Valve Repair System Device, Vascular | Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid | 2020 |
| 2020-12-31 | Siemens Medical Solutions USA, Inc. | $43 | Charitable Contribution | In-kind items and services | 2020 | ||
| 2020-12-22 | Eli Lilly and Company | $21,030 | Research payment | Cash or cash equivalent | A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY383 | 2020 | |
| 2020-12-16 | JAZZ PHARMACEUTICALS INC. | $76,217 | Research payment | In-kind items and services | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A | 2020 |
| 2020-12-15 | Linvatec Corporation | $530 | Grant | In-kind items and services | MICROFREE Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-12-11 | Aesculap Implant Systems, LLC | $500 | Gift | Cash or cash equivalent | 2020 | ||
| 2020-12-08 | Karyopharm Therapeutics Inc. | $8,000 | Research payment | Cash or cash equivalent | XPOVIO Drug, Oncology | XPORT-COV-1001 | 2020 |
| 2020-12-08 | Karyopharm Therapeutics Inc. | $2,750 | Research payment | Cash or cash equivalent | XPOVIO Drug, Oncology | XPORT-COV-1001 | 2020 |
| 2020-12-08 | Karyopharm Therapeutics Inc. | $1,400 | Research payment | Cash or cash equivalent | XPOVIO Drug, Oncology | XPORT-COV-1001 | 2020 |
| 2020-12-08 | Karyopharm Therapeutics Inc. | $1,200 | Research payment | Cash or cash equivalent | XPOVIO Drug, Oncology | XPORT-COV-1001 | 2020 |
| 2020-12-04 | Baxter Healthcare | $4,444 | Research payment | Cash or cash equivalent | Fluid Systems - Research Devel Biological, Fluid Systems | Peripheral IntraVenous Analysis -PIVA- compared with intermittent pulmonary capillary wedge pressure -PCWP-- in patients | 2020 |
| 2020-12-03 | FUJIFILM SonoSite, Inc. | $196 | Education | In-kind items and services | S II Ultrasound System Device, Medical Device | 2020 | |
| 2020-11-19 | PFIZER INC. | $1,270 | Research payment | Cash or cash equivalent | A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST | 2020 | |
| 2020-11-19 | PFIZER INC. | $66 | Research payment | Cash or cash equivalent | A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST | 2020 | |
| 2020-11-16 | Regeneron Pharmaceuticals, Inc. | $23,380 | Research payment | Cash or cash equivalent | A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies fo | 2020 | |
| 2020-11-16 | Regeneron Pharmaceuticals, Inc. | $1,539 | Research payment | Cash or cash equivalent | A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies fo | 2020 | |
| 2020-11-13 | JAZZ PHARMACEUTICALS INC. | $76,217 | Research payment | In-kind items and services | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A | 2020 |
| 2020-10-28 | PFIZER INC. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-10-26 | Genentech, Inc. | $841 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2020 |
| 2020-10-15 | Surmodics, Inc. | $1,353 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-09-30 | Abbott Laboratories | $45 | Research payment | In-kind items and services | MitraClip Device, Vascular | Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca | 2020 |
| 2020-09-03 | Pharmacyclics LLC, an AbbVie Company | $1,750 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-08-27 | Genentech, Inc. | $841 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2020 |
| 2020-08-21 | Pharmacyclics LLC, an AbbVie Company | $175 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-08-20 | Medical Device Business Services, Inc. | $20,000 | Grant | Cash or cash equivalent | 2020 | ||
| 2020-08-12 | JAZZ PHARMACEUTICALS INC. | $127,029 | Research payment | In-kind items and services | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A | 2020 |
| 2020-07-30 | Baxter Healthcare | $1,125 | Research payment | Cash or cash equivalent | Fluid Systems - Research Devel Biological, Fluid Systems | Peripheral IntraVenous Analysis -PIVA- compared with intermittent pulmonary capillary wedge pressure -PCWP-- in patients | 2020 |
| 2020-07-23 | AXOGEN | $3,850 | Research payment | Cash or cash equivalent | AVANCE NERVE GRAFT | Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair (RECON) | 2020 |
| 2020-07-21 | Pharmacyclics LLC, an AbbVie Company | $175 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-07-06 | Genentech USA, Inc. | $775 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | OCREVUS Biological, Immunology | 2020 | |
| 2020-06-30 | Abbott Laboratories | $150 | Research payment | In-kind items and services | TriClip Transcatheter Tricuspid Valve Repair System Device, Vascular | Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid | 2020 |
| 2020-06-24 | Abbott Laboratories | $3,099 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2020 | ||
| 2020-06-16 | Pharmacyclics LLC, an AbbVie Company | $175 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-06-10 | Stryker Corporation | $1,207 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | NONE Device, NONE | 2020 | |
| 2020-05-27 | PFIZER INC. | $441 | Research payment | Cash or cash equivalent | A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST | 2020 | |
| 2020-05-19 | Genentech, Inc. | $1,682 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2020 |
| 2020-04-08 | Zimmer Biomet Holdings, Inc. | $1,095 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2020 | |
| 2020-04-08 | Incyte Corporation | $12 | Research payment | Cash or cash equivalent | A Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub | 2020 | |
| 2020-04-08 | Incyte Corporation | $12 | Research payment | Cash or cash equivalent | A Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub | 2020 | |
| 2020-04-08 | Incyte Corporation | $12 | Research payment | Cash or cash equivalent | A Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub | 2020 | |
| 2020-03-25 | Stryker Corporation | $1,083 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | HOFFMANN Device, TRAUMA & EXTREMETIES | 2020 | |
| 2020-03-10 | Pharmacyclics LLC, an AbbVie Company | $175 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-03-07 | Allergan, Inc. | $1,200 | Education | Cash or cash equivalent | 2020 | ||
| 2020-02-20 | AstraZeneca Pharmaceuticals LP | $7,956 | Research payment | Cash or cash equivalent | LYNPARZA Drug, Oncology | A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Pati | 2020 |
| 2020-02-18 | UCB, Inc. | $775 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-02-11 | Celgene Corporation | $22,125 | Research payment | Cash or cash equivalent | Revlimid Drug, Hematology | Celgene - Connect MM | 2020 |
| 2020-02-05 | Surmodics, Inc. | $700 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-01-30 | Abbott Laboratories | $1,750 | Research payment | Cash or cash equivalent | Proclaim DRG Neurostimulator System Device, Cardiac Arrhythmias and Heart Failure | TARGET: A Post-Approval Study to Evaluate Targeted SCS Spinal Cord Stimulation (SCS) Dorsal Root Ganglion (DRG) Stimulat | 2020 |
| 2020-01-14 | Pharmacyclics LLC, an AbbVie Company | $175 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
| 2020-01-02 | Pharmacyclics LLC, an AbbVie Company | $175 | Research payment | Cash or cash equivalent | Imbruvica Drug, Oncology | PCYC-1134M-CA | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Indianapolis city, IN, county Marion County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Indianapolis city, IN | County Marion County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 885,860 | 975,809 | 6,851,073 |
| Population, 2020 census P1 | 887,642 | 977,203 | 6,785,528 |
| Median age B01002 | 34.3 | 34.4 | 38.1 |
| Under 18 B01001 | 24.8% | 25.0% | 23.3% |
| 65 and over B01001 | 13.1% | 13.2% | 16.8% |
| Households B11001 | 362,961 | 400,432 | 2,716,009 |
| Foreign born B05002 | 12.7% | 12.6% | 6.3% |
| Median household income B19013 | $66,219 | $66,346 | $71,957 |
| Median family income B19113 | $82,766 | $83,024 | $90,767 |
| Per capita income B19301 | $37,680 | $37,704 | $38,351 |
| Poverty rate B17001 | 15.8% | 15.3% | 12.3% |
| Unemployment rate B23025 | 5.1% | 5.0% | 4.3% |
| Civilian labor force B23025 | 472,847 | 520,799 | 3,472,016 |
| Mean commute (minutes) B08013 | 24.6 | 24.5 | 24.1 |
| Bachelor's degree or higher B15003 | 34.9% | 34.8% | 29.5% |
| Housing units B25001 | 401,428 | 441,040 | 2,976,568 |
| Owner-occupied B25003 | 56.0% | 56.5% | 70.6% |
| Renters B25003 | 44.0% | 43.5% | 29.4% |
| Median home value B25077 | $224,800 | $224,000 | $218,200 |
| Median gross rent B25064 | $1,156 | $1,153 | $1,062 |
| White, not Hispanic B03002 | 48.9% | 49.5% | 75.4% |
| Black B03002 | 27.6% | 27.1% | 9.1% |
| Hispanic or Latino B03002 | 13.8% | 13.8% | 8.6% |
| Asian B03002 | 4.2% | 4.0% | 2.6% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Indianapolis city, IN.
Comments